Acute lead-induced vasoconstriction in the vascular beds of isolated perfused rat tails is endothelium-dependent

Chronic lead exposure induces hypertension in humans and animals, affecting endothelial function. However, studies concerning acute cardiovascular effects are lacking. We investigated the effects of acute administration of a high concentration of lead acetate (100 µΜ) on the pressor response to phenylephrine (PHE) in the tail vascular bed of male Wistar rats. Animals were anesthetized with sodium pentobarbital and heparinized. The tail artery was dissected and cannulated for drug infusion and mean perfusion pressure measurements. Endothelium and vascular smooth muscle relaxation were tested with acetylcholine (5 µg/100 µL) and sodium nitroprusside (0.1 µg/100 µL), respectively, in arteries precontracted with 0.1 µM PHE. Concentration-response curves to PHE (0.001-300 µg/100 µL) were constructed before and after perfusion for 1 h with 100 µΜ lead acetate. In the presence of endothelium (E+), lead acetate increased maximal response (Emax) (control: 364.4 ± 36, Pb2+: 480.0 ± 27 mmHg; P < 0.05) and the sensitivity (pD2; control: 1.98 ± 0.07, 2.38 ± 0.14 log mM) to PHE. In the absence of endothelium (E-) lead had no effect but increased baseline perfusion pressure (E+: 79.5 ± 2.4, E-: 118 ± 2.2 mmHg; P < 0.05). To investigate the underlying mechanisms, this protocol was repeated after treatment with 100 µM L-NAME, 10 µM indomethacin and 1 µM tempol in the presence of lead. Lead actions on Emax and pD2 were abolished in the presence of indomethacin, and partially abolished with L-NAME and tempol. Results suggest that acute lead administration affects the endothelium, releasing cyclooxygenase-derived vasoconstrictors and involving reactive oxygen species.

Lead reduces tension development and the myosin ATPase activity of the rat right ventricular myocardium

Lead (Pb2+) poisoning causes hypertension, but little is known regarding its acute effects on cardiac contractility. To evaluate these effects, force was measured in right ventricular strips that were contracting isometrically in 45 male Wistar rats (250-300 g) before and after the addition of increasing concentrations of lead acetate (3, 7, 10, 30, 70, 100, and 300 µM) to the bath. Changes in rate of stimulation (0.1-1.5 Hz), relative potentiation after pauses of 15, 30, and 60 s, effect of Ca2+ concentration (0.62, 1.25, and 2.5 mM), and the effect of isoproterenol (20 ng/mL) were determined before and after the addition of 100 µM Pb2+. Effects on contractile proteins were evaluated after caffeine treatment using tetanic stimulation (10 Hz) and measuring the activity of the myosin ATPase. Pb2+ produced concentration-dependent force reduction, significant at concentrations greater than 30 µM. The force developed in response to increasing rates of stimulation became smaller at 0.5 and 0.8 Hz. Relative potentiation increased after 100 µM Pb2+ treatment. Extracellular Ca2+ increment and isoproterenol administration increased force development but after 100 µM Pb2+ treatment the force was significantly reduced suggesting an effect of the metal on the sarcolemmal Ca2+ influx. Concentration of 100 µM Pb2+ also reduced the peak and plateau force of tetanic contractions and reduced the activity of the myosin ATPase. Results showed that acute Pb2+ administration, although not affecting the sarcoplasmic reticulum activity, produces a concentration-dependent negative inotropic effect and reduces myosin ATPase activity. Results suggest that acute lead administration reduced myocardial contractility by reducing sarcolemmal calcium influx and the myosin ATPase activity. These results also suggest that lead exposure is hazardous and has toxicological consequences affecting cardiac muscle.

Diverse effects of renal denervation on ventricular hypertrophy and blood pressure in DOCA-salt hypertensive rats

Cardiac hypertrophy that accompanies hypertension seems to be a phenomenon of multifactorial origin whose development does not seem to depend on an increased pressure load alone, but also on local growth factors and cardioadrenergic activity. The aim of the present study was to determine if sympathetic renal denervation and its effects on arterial pressure level can prevent cardiac hypertrophy and if it can also delay the onset and attenuate the severity of deoxycorticosterone acetate (DOCA)-salt hypertension. DOCA-salt treatment was initiated in rats seven days after uninephrectomy and contralateral renal denervation or sham renal denervation. DOCA (15 mg/kg, sc) or vehicle (soybean oil, 0.25 ml per animal) was administered twice a week for two weeks. Rats treated with DOCA or vehicle (control) were provided drinking water containing 1% NaCl and 0.03% KCl. At the end of the treatment period, mean arterial pressure (MAP) and heart rate measurements were made in conscious animals. Under ether anesthesia, the heart was removed and the right and left ventricles (including the septum) were separated and weighed. DOCA-salt treatment produced a significant increase in left ventricular weight/body weight (LVW/BW) ratio (2.44 ± 0.09 mg/g) and right ventricular weight/body weight (RVW/BW) ratio (0.53 ± 0.01 mg/g) compared to control (1.92 ± 0.04 and 0.48 ± 0.01 mg/g, respectively) rats. MAP was significantly higher (39%) in DOCA-salt rats. Renal denervation prevented (P>0.05) the development of hypertension in DOCA-salt rats but did not prevent the increase in LVW/BW (2.27 ± 0.03 mg/g) and RVW/BW (0.52 ± 0.01 mg/g). We have shown that the increase in arterial pressure level is not responsible for cardiac hypertrophy, which may be more related to other events associated with DOCA-salt hypertension, such as an increase in cardiac sympathetic activity.

Estudo Químico-Biológico de Pyrostegia venusta (Ker Gawl.) Miers (Bignoniaceae)

Este trabalho descreve a investigação química e biológica do extrato bruto e das partições hexano e acetato de etila, das folhas de Pyrostegia venusta (Ker Gawl.) Miers, popularmente conhecida como “cipó de São João”. P. venusta é classificada botanicamente como uma liana de porte mediano, tendo como característica uma exuberante floração vermelha, e por isso, sendo utilizada como planta ornamental. Essa planta possui uma larga utilização na medicina popular, sendo utilizada no tratamento de vitiligo, diarreia, bronquite, resfriado, icterícia e infecções. Os objetivos deste trabalho foram identificar as classes de metabólitos secundários presentes, avaliar o potencial antioxidante das amostras de P. vesnuta (extrato bruto, frações acetato de etila e hexano), quantificar o teor de flavonoides no extrato bruto, verificar a segurança do uso dessa planta, em termos de viabilidade celular (VC) frente à macrófagos murinos (RAW 264.7) (ensaio de imunotoxicidade). Adicionalmente os resultados de viabilidade celular foram comparados com quatro compostos anti-inflamatórios comerciais (ácido acetilsalicílico, indometacina, betametasona e piroxicam), e testar o extrato bruto quanto à inibição de catepsinas K e V. Os testes de identificação fitoquímica confirmaram a presença de flavonoides, cumarinas e esteroides nas amostras. A metodologia cromatográfica associada à análises por espectrometria de massas, levou a identificação dos compostos: fitol (1), sitosterol (2), estigmasterol (3) e campesterol (4). O extrato bruto demonstrou ter atividade inibitória frente as duas catepsinas testadas (K e V). A fração acetato de etila foi a que apresentou maior atividade antioxidante nas metodologias de inibição do radical DPPH (IC50 38,62 μg/mL) e radical ABTS (IC50 27,58 μg/mL). O teor de flavonoides total para o extrato bruto foi de 148,5±7,65 μg/mg (14,85 % (m/m)), o que justifica a observada atividade antioxidante, já que estes possuem atividade antioxidante. As amostras de P. venusta obtiveram valores de VC maiores do que os anti-inflamatórios comerciais, estes apresentaram VC abaixo do controle negativo, assim como o extrato bruto e a fração acetato de etila, a fração hexano obteve valores acima do controle negativo, sendo estes os maiores resultados de VC entre as amostras de P. venusta.